Please login to the form below

Social listening report: Is COVID-19 impacting clinical trial recruitment?

The short answer, perhaps obviously, is yes.

Here at COUCH Health, we’ve been doing some social listening to work out how the COVID-19 pandemic is affecting clinical trials and product development for other conditions. Of course, at the moment, most online discussions about clinical research surround the latest developments in COVID-19 trials. Everyone is working hard to investigate vaccines, better diagnostic tests and treatments. The most common emotion revealed in our analysis was fear. And this isn’t surprising, since the uncertainty of the pandemic is affecting us all in so many ways.

Outside of COVID-19 research, clinical trials are being impacted regardless of indication. The FDA has encouraged clinical trials to pause unless they serve an immediate benefit. Some trials are taking the opportunity to decentralise their study assessments, using saliva collection kits that can be used at home and posted for testing instead. That way, the trial can keep move forwards and enrolment can still be encouraged. But it’s not just the routine appointments for participants that are being affected:

  • Screening is unable to go ahead as patients can’t visit study clinics and many clinicians are working from home, where they can.
  • Research groups that run lab work are putting operations on hold to devote resources to COVID-19.
  • COVID-19 testing is not part of trial protocols and patients may need to be removed from study populations for safety reasons.

Our insights have revealed that lots of people are worried about attending appointments because of the risks of COVID-19. These feelings would undoubtedly translate to the clinical trials, too.

“Must admit I am not looking forward to going to the hospital as I believe they could be riddled with COVID-19.”
– MS patient

And a survey in the US found that almost 40% of study sites believe that patients will be less willing to consentto take part in a new clinical trial.

Like never before, COVID-19 has forced the pharmaceutical industry to step up, expedite processes and re-evaluate priorities. While this does mean that resources are being diverted to focus on COVID-19, it’s equally important that progress doesn’t stop for other conditions. Clinical trial teams will need to adapt, decentralise, and go the extra mile to reassure patients that taking part is safe.

For more insights on how the clinical trial space is changing in light of COVID-19, take a look at more of our findings by downloading the document. And if you’re wondering how your study could benefit from improved patient engagement or virtual activities during these challenging times, we’re here to help.

This blog was originally posted here:


  COVID-19 Social Listening Report
PDF File: 1.8 MB

18th April 2020


  COVID-19 Social Listening Report
PDF File: 1.8 MB



Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Suite 2.10, Jactin House
24 Hood Street
M4 6WX
United Kingdom

Latest content on this profile

Outsourcing in Clinical Trials 2020 Virtual Conference
We recently had the pleasure of sponsoring and attending the Outsourcing in Clinical Trials (OCT) virtual conference. Although we would have loved to have met everyone in person, it was great to listen to those who share our passions and values and chat with everyone throughout the day. Read on for a low down of the talks that resonated with the team at COUCH Health the most.
COUCH Health
We are COUCH Health
Making health human means that everything we do puts people first. __Pharmaceutical, biotech and life science companies turn to us to help them build strong connections with, and improve outcomes for, the people who matter most: patients.We do this by improving patient insights, patient recruitment and patient retention for clinical trials with creative solutions that build better experiences and outcomes for patients. __We specialise in bringing the human touch to clinical trials by:1. Generating deep insights that build patient-centric clinical trial materials. 2. Creating patient engagement materials that are actually read and understood that will lead to improved patient recruitment and patient retention. 3. Developing compelling creative advertising and marketing that improves clinical trial patient recruitment and retention. __Here a snapshot of our services:Patient recruitment and retention planning Study and site support Patient recruitment advertising campaigns Patient advocacy, and diversity & inclusion Patient retention platforms __Please feel free to visit our website for further information
COUCH Health
WHITE PAPER 06: Uncover the true potential of clinical study websites
With 8/10 prospective patients beginning their journey to care online, 43% of patients searching the internet to for clinical study information, and 70,000 health related Google searches made each day, information on your clinical study needs to be online and easy to access.
COUCH Health
CHECKLIST 03: Create patient materials that recruit and retain to your clinical trials
From content strategy to copy, design to imagery, our checklist guides you through key considerations to create powerful patient engagement strategies and materials.
COUCH Health
Understanding religious and cultural barriers to clinical trial participation
In this blog post we discuss how you can understand cultural barriers to clinical trial participation.
COUCH Health
Why we need to improve diverse representation in clinical trials
Diversity in clinical trials: The powerful need to improve it!  “One size fits all” is rapidly becoming an outdated concept in modern-day life, and medical research is no exception. Without diversity in clinical trials, any major discoveries are only valid for the sample of the population used.
COUCH Health